All In Biotech

Free tool

FAERS Monitor: Haldol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018701 or its brand name (Haldol, Haloperidol Decanoate). Reports on generic versions are filed under their own applications.

Reports

1,743

Serious

1,546

89% of reports

Hospitalization

800

Death reported

153

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • weight increased241
  • drug ineffective168
  • extrapyramidal disorder147
  • off label use134
  • akathisia127
  • drug interaction116
  • suicide attempt107
  • leukopenia97
  • toxicity to various agents97
  • neuroleptic malignant syndrome96
  • product use in unapproved indication84
  • treatment noncompliance73
  • tremor73
  • therapeutic product effect incomplete68
  • euphoric mood67

Reports by year received

View as table
YearReports
200430
200534
200642
2007190
200819
200965
201031
201126
201241
201350
201459
201576
201649
201764
201845
201987
202077
2021101
2022134
2023165
2024131
2025146
202681

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,416 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
akathisiaSignal127113.495.813,910
neuroleptic malignant syndromeSignal9698.581.09,095
euphoric moodSignal6779.462.85,080
extrapyramidal disorderSignal14771.961.510,151
leukopeniaSignal9723.419.32,063
suicide attemptSignal10721.317.72,055
treatment noncomplianceSignal7316.112.91,022
weight increasedSignal24113.011.62,683
therapeutic product effect incompleteSignal6811.59.1646
drug interactionSignal1168.87.4803
toxicity to various agentsSignal976.95.7491
tremorSignal735.34.2253
product use in unapproved indicationSignal844.13.3195
off label use1341.81.653
drug ineffective1681.51.333

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.